ebomi
Colour theme
Sign in
Insider · CIK 0001493215

RTW Investments, LP

CIK 0001493215 Name as filed on the most recent filing

Filed as RTW Investments, LP (47)

79 transaction lines · from 47 filings · filed 2019-04-18 to 2026-04-29 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-04-27 S, Open-market sale Orchestra BioMed Holdings, Inc.OBIO 132, disposed Open Form 4 filing 0001231919-26-000427
2026-04-20 P, Open-market purchase Kailera Therapeutics, Inc.KLRA 8,000,000, acquired Open Form 4 filing 0001231919-26-000390
2025-04-30 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 149,201, acquired Open Form 4 filing 0001062993-25-008272
2025-04-29 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 126,500, acquired Open Form 4 filing 0001062993-25-008205
2022-11-04 S, Open-market sale DermTech, Inc.DMTK 176,660, disposed Open Form 4 filing 0000902664-22-004774
2022-10-06 P, Open-market purchase Rocket Pharmaceuticals, Inc.RCKT 19,999,997, acquired Open Form 4 filing 0000902664-22-004508
2022-09-23 S, Open-market sale Landos Biopharma, Inc.LABP 207,000, disposed Open Form 4 filing 0000902664-22-004363
2022-09-07 P, Open-market purchase Milestone Pharmaceuticals Inc.MIST 13,564,484, acquired Open Form 4 filing 0000902664-22-004219
2022-09-07 S, Open-market sale Milestone Pharmaceuticals Inc.MIST 13,564,484, disposed Open Form 4 filing 0000902664-22-004219
2022-01-18 P, Open-market purchase Renovacor, Inc.RCOR 355,520, acquired Open Form 4 filing 0000902664-22-000395
2022-01-14 P, Open-market purchase Renovacor, Inc.RCOR 2 lines 1,205,436, acquired Open Form 4 filing 0000902664-22-000269
2022-01-13 P, Open-market purchase Renovacor, Inc.RCOR 2,217, acquired Open Form 4 filing 0000902664-22-000269
2022-01-12 P, Open-market purchase Renovacor, Inc.RCOR 14,957, acquired Open Form 4 filing 0000902664-22-000269
2022-01-06 P, Open-market purchase Renovacor, Inc.RCOR 410,368, acquired Open Form 4 filing 0000902664-22-000093
2022-01-05 P, Open-market purchase Renovacor, Inc.RCOR 801,530, acquired Open Form 4 filing 0000902664-22-000093
2022-01-04 P, Open-market purchase Renovacor, Inc.RCOR 31, acquired Open Form 4 filing 0000902664-22-000093
2022-01-03 P, Open-market purchase Renovacor, Inc.RCOR 3,506, acquired Open Form 4 filing 0000902664-22-000009
2021-12-30 P, Open-market purchase Renovacor, Inc.RCOR 29,944, acquired Open Form 4 filing 0000902664-22-000009
2021-12-29 P, Open-market purchase Renovacor, Inc.RCOR 3,832, acquired Open Form 4 filing 0000902664-22-000009
2021-12-27 P, Open-market purchase Renovacor, Inc.RCOR 39,209, acquired Open Form 4 filing 0000902664-21-005405
2021-12-23 P, Open-market purchase Renovacor, Inc.RCOR 490,978, acquired Open Form 4 filing 0000902664-21-005405
2021-12-22 P, Open-market purchase Renovacor, Inc.RCOR 27,830, acquired Open Form 4 filing 0000902664-21-005366
2021-12-21 P, Open-market purchase Renovacor, Inc.RCOR 2 lines 43,765, acquired Open Form 4 filing 0000902664-21-005366
2021-12-20 P, Open-market purchase Renovacor, Inc.RCOR 2 lines 1,037,419, acquired Open Form 4 filing 0000902664-21-005366
2021-11-17 P, Open-market purchase Renovacor, Inc.RCOR 190,447, acquired Open Form 4 filing 0000902664-21-005034
2021-11-16 P, Open-market purchase Renovacor, Inc.RCOR 381,690, acquired Open Form 4 filing 0000902664-21-005034
2021-11-15 P, Open-market purchase Renovacor, Inc.RCOR 2 lines 38,902, acquired Open Form 4 filing 0000902664-21-005034
2021-11-12 P, Open-market purchase Renovacor, Inc.RCOR 5,364, acquired Open Form 4 filing 0000902664-21-004937
2021-11-11 P, Open-market purchase Renovacor, Inc.RCOR 2,691, acquired Open Form 4 filing 0000902664-21-004937
2021-11-09 P, Open-market purchase Renovacor, Inc.RCOR 73,829, acquired Open Form 4 filing 0000902664-21-004937
2021-11-08 P, Open-market purchase Renovacor, Inc.RCOR 825,074, acquired Open Form 4 filing 0000902664-21-004782
2021-11-05 P, Open-market purchase Renovacor, Inc.RCOR 2 lines 119,611, acquired Open Form 4 filing 0000902664-21-004782
2021-11-04 P, Open-market purchase Renovacor, Inc.RCOR 464,992, acquired Open Form 4 filing 0000902664-21-004782
2021-09-02 P, Open-market purchase Renovacor, Inc.RCOR 8,000,000, acquired Open Form 4 filing 0000919574-21-005731
2021-08-04 P, Open-market purchase Avidity Biosciences, Inc.RNA 14,400,000, acquired Open Form 4 filing 0001826466-21-000107
2021-05-11 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 29,023,490, disposed Open Form 4 filing 0001493152-21-011359
2021-05-07 S, Open-market sale Tarsus Pharmaceuticals, Inc.TARS 13,491,000, disposed Open Form 4 filing 0001493152-21-010811
2021-03-16 P, Open-market purchase Prometheus Biosciences, Inc.RXDX 15,200,000, acquired Open Form 4 filing 0001493152-21-006147
2021-02-04 P, Open-market purchase Landos Biopharma, Inc.LABP 10,000,000, acquired Open Form 4 filing 0001493152-21-002881
2021-01-07 P, Open-market purchase DermTech, Inc.DMTK 5,900,000, acquired Open Form 4 filing 0001493152-21-000788
2020-12-10 P, Open-market purchase Rocket Pharmaceuticals, Inc.RCKT 13,872,320, acquired Open Form 4 filing 0001493152-20-023575
2020-09-18 P, Open-market purchase Athira Pharma, Inc.ATHA 12,750,000, acquired Open Form 4 filing 0001493152-20-018188
2020-06-16 P, Open-market purchase Avidity Biosciences, Inc.RNA 17,100,000, acquired Open Form 4 filing 0001209191-20-036979
2020-04-01 P, Open-market purchase DermTech, Inc.DMTK 276,316, acquired Open Form 4 filing 0001493152-20-005632
2020-03-31 P, Open-market purchase DermTech, Inc.DMTK 56,321, acquired Open Form 4 filing 0001493152-20-005632

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. RTW INVESTMENTS, LP, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001493215

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.